For the year ending 2025-12-31, JBTM had $1,228,400K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| (loss) income from continuing operations | -49,700 |
| Depreciation | 87,400 |
| Amortization | 178,800 |
| Stock-based compensation | 23,200 |
| Pension and other post-retirement benefits expense | 148,400 |
| Deferred income taxes | -79,600 |
| Loss on deal contingent hedge | 0 |
| Other | -59,500 |
| Trade receivables, net and contract assets | -13,700 |
| Inventories | 53,900 |
| Accounts payable, trade and other | -16,300 |
| Advance and progress payments | 20,800 |
| Accrued pension and other post-retirement benefits, net | -5,100 |
| Income taxes on gain from sale of aerotech | 0 |
| Other assets and liabilities, net | -14,500 |
| Cash provided by continuing operating activities | 341,700 |
| Acquisitions, net of cash acquired | 1,746,000 |
| (payments) proceeds from discontinued operations | -100 |
| Investment in unconsolidated affiliate | 0 |
| Capital expenditures | 103,600 |
| Proceeds from disposal of assets | 6,600 |
| Purchase of marketable securities | 0 |
| Proceeds from sale of marketable securities | 0 |
| Cash (required) provided by continuing investing activities | -1,843,100 |
| Net proceeds (payments) from short-term debt | 1,200 |
| Repayment of domestic credit facility | -2,381,600 |
| Net proceeds (payments) from domestic credit facilities, net of debt issuance cost-Term Loan BAnd Domestic Credit Facility Amendment | 1,528,500 |
| Proceeds from term loan b, net of debt issuance costs-Marcel Transaction Debt | 896,900 |
| Repayment of term loan b | 6,800 |
| Proceeds from issuance of 2030 convertible senior notes, net of debt issuance costs | 559,400 |
| Purchase of convertible bond hedge | 78,800 |
| Proceeds from sale of warrants | 51,100 |
| Payment of debt issuance costs related to the marel transaction-Secured Debt | 13,400 |
| Acquisition of noncontrolling interest of marel | 24,400 |
| Repayment of term loan b | 8,300 |
| Settlement of deal contingent hedge | 42,500 |
| Proceeds from settlement of cross currency swaps | 0 |
| Common stock repurchases | 0 |
| Dividends | 20,900 |
| Other | -2,300 |
| Cash provided (required) by continuing financing activities | 458,100 |
| Net (decrease) increase in cash from continuing operations | -1,043,300 |
| Cash provided (required) by operating activities of discontinued operations, net | 0 |
| Cash required by investing activities of discontinued operations, net | 0 |
| Net cash provided (required) by discontinued operations | 0 |
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | 1,400 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -1,041,900 |
| Add net increase (decrease) in cash, cash equivalents and restricted cash | 1,228,400 |
| Less cash, cash equivalents and restricted cash from discontinued operations, end of period | 0 |
| Cash, cash equivalents and restricted cash from continuing operations, end of period | 186,500 |
JBT MAREL Corp (JBTM)
JBT MAREL Corp (JBTM)